Pneumothorax in cystic fibrosis
Pneumothorax in cystic fibrosis
复制标题
DOI：
10.1097/mcp.0b013e328345e1f8
复制
发表时间：
2011-07-01
影响因子：
3.3
通讯作者：
Flume, Patrick A.
中科院分区：
文献类型：
--
作者：
Flume, Patrick A.
Purpose of reviewCystic fibrosis (CF) is a complex genetic disease affecting many organs, although 85% of the mortality is a result of lung disease. The natural history of the lung disease consists of early and persistent infection, an exaggerated inflammatory response, structural airway changes (i.e. bronchiectasis), and progressive airways obstruction, ultimately resulting in respiratory failure. As airways disease worsens, there is an increased likelihood of respiratory complications, such as pneumothorax, that may be serious. This review describes our current understanding of the pathogenesis of pneumothorax in CF and its treatment.Recent findingsThe CF Foundation Pulmonary Therapies Committee recently published their recommendations for the treatment of hemoptysis and pneumothorax. As insufficient data exist from which a systematic review of the literature could be used to develop guidelines, the recommendations were derived from a formalized expert panel consensus process.SummaryWe now have recommendations on specific care of the patient with CF who has a pneumothorax.
